Cargando…
Cellular reprogramming for pancreatic β-cell regeneration: clinical potential of small molecule control
Recent scientific breakthroughs in stem cell biology suggest that a sustainable treatment approach to cure diabetes mellitus (DM) can be achieved in the near future. However, the transplantation complexities and the difficulty in obtaining the stem cells from adult cells of pancreas, liver, bone mor...
Autores principales: | Pandian, Ganesh N, Taniguchi, Junichi, Sugiyama, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984496/ https://www.ncbi.nlm.nih.gov/pubmed/24679123 http://dx.doi.org/10.1186/2001-1326-3-6 |
Ejemplares similares
-
A Multi‐target Small Molecule for Targeted Transcriptional Activation of Therapeutically Significant Nervous System Genes
por: Wei, Yulei, et al.
Publicado: (2016) -
Strategies To Modulate Heritable Epigenetic Defects in Cellular Machinery: Lessons from Nature
por: Pandian, Ganesh N., et al.
Publicado: (2012) -
A synthetic small molecule for rapid induction of multiple pluripotency genes in mouse embryonic fibroblasts
por: Pandian, Ganesh N., et al.
Publicado: (2012) -
Commentary: Cellular reprogramming for myocardial regeneration and beyond
por: Akhmerov, Akbarshakh, et al.
Publicado: (2020) -
A synthetic DNA-binding inhibitor of SOX2 guides human induced pluripotent stem cells to differentiate into mesoderm
por: Taniguchi, Junichi, et al.
Publicado: (2017)